Showing results (81-90 of 191) with videos related to

Sort By:
Pageof 20
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 26, 2009
Tumor microenvironment of metastasis in human breast carcinoma: a potential prognostic marker linked to hematogenous disseminationBrian D Robinson, Gabriel L Sica, Yi-Fang Liu, et al.
Biomolecules|September 7, 2016
An Epigenomic Approach to Improving Response to Neoadjuvant Cisplatin Chemotherapy in Bladder CancerEvanguelos Xylinas, Melanie R Hassler, Dazhong Zhuang, et al.
Oncology Letters|July 17, 2018
The dog as an animal model for bladder and urethral urothelial carcinoma: Comparative epidemiology and histologySimone de Brot, Brian D Robinson, Tim Scase, et al.
Oncology Reports|April 25, 2013
Estrogen receptor-β expression and pharmacological targeting in bladder cancerEric C Kauffman, Brian D Robinson, Martin Downes, et al.
Molecular Carcinogenesis|June 21, 2022
Transcriptional and metabolic remodeling in clear cell renal cell carcinoma caused by ATF4 activation and the integrated stress response (ISR)Johannes C van der Mijn, Qiuying Chen, Kristian B Laursen, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|December 11, 2012
Cytoplasmic PTEN protein loss distinguishes intraductal carcinoma of the prostate from high-grade prostatic intraepithelial neoplasiaTamara L Lotan, Berrak Gumuskaya, Hameed Rahimi, et al.
Translational Oncology|December 23, 2019
Combined Metabolomics and Genome-Wide Transcriptomics Analyses Show Multiple HIF1α-Induced Changes in Lipid Metabolism in Early Stage Clear Cell Renal Cell CarcinomaJohannes C van der Mijn, Leiping Fu, Francesca Khani, et al.
Nature Communications|January 8, 2024
Distinct mesenchymal cell states mediate prostate cancer progressionHubert Pakula, Mohamed Omar, Ryan Carelli, et al.
NPJ Precision Oncology|May 4, 2021
Computer extracted gland features from H&E predicts prostate cancer recurrence comparably to a genomic companion diagnostic test: a large multi-site studyPatrick Leo, Andrew Janowczyk, Robin Elliott, et al.
Frontiers in Endocrinology|October 20, 2022
Exploring anti-androgen therapies in hormone dependent prostate cancer and new therapeutic routes for castration resistant prostate cancerAnna E Harris, Veronika M Metzler, Jennifer Lothion-Roy, et al.
Pageof 20